Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.600
-0.040 (-1.52%)
At close: Feb 11, 2026, 4:00 PM EST
2.650
+0.050 (1.92%)
Pre-market: Feb 12, 2026, 5:26 AM EST
Absci Market Cap
Absci has a market cap or net worth of $390.97 million as of February 12, 2026. Its market cap has decreased by -11.35% in one year.
Market Cap
390.97M
Enterprise Value
244.71M
1-Year Change
-11.35%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has decreased from $423.19M to $390.97M, a decrease of -7.62%. That is a compound annual growth rate of -1.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 390.97M | -25.50% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | 423.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Niagen Bioscience | 409.26M |
| Immutep | 409.10M |
| Benitec Biopharma | 399.07M |
| Monopar Therapeutics | 396.88M |
| Entrada Therapeutics | 396.63M |
| PepGen | 393.93M |
| NovaBridge Biosciences | 390.84M |
| Greenwich LifeSciences | 384.19M |